Abstract
CATIONIC drugs of different types and structures (antihistaminics, antiarrhythmics, sedatives, opiates, cytostatics and antibiotics, for example) are excreted in mammals by epithelial cells of the renal proximal tubules and by hepatocytes in the liverl–4. In the proximal tubules, two functionally disparate transport systems are involved which are localized in the basolateral and luminal plasma membrane and are different from the previously identified neuronal monoamine transporters and ATP-dependent multidrug exporting proteins1–3,5–12. Here we report the isolation of a complementary DNA from rat kidney that encodes a 556-amino-acid membrane protein, OCT1, which has the functional characteristics of organic cation uptake over the basolateral membrane of renal proximal tubules and of organic cation uptake into hepatocytes. OCT1 is not homologous to any other known protein and is found in kidney, liver and intestine. As OCT1 translocates hydrophobic and hydrophilic organic cations of different structures, it is considered to be a new prototype of polyspecific transporters that are important for drug elimination.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Roch-Ramel, F., Besseghir, K. & Murer, H. in Handbook of Physiology 8, Renal Physiology Vol. 2 (ed. Windhager, E. E.) 2189–2262 (Oxford Univ. Press, Oxford, 1992).
Ullrich, K. J. Biochim. biophys. Acta 1197, 45–62 (1994).
Pritchard, J. B. & Miller, D. S. in The Kidney: Physiology and Pathophysiology (eds Seldin, D. W. & Giebisch, G.) 2921–2945 (Raven, New York, 1992).
Meijer, D. K. F., Mol, W. E. M., Müller, M. & Kurz, G. J. Pharmakin. Biopharmac. 18, 35–70 (1990).
Schuldiner, S. J. Neurochem. 62, 2067–2078 (1994).
Schloss, P., Mayser, W. & Betz, H. FEBS Lett. 307, 76–80 (1992).
Gottesman, M. M. & Pastan, I. A. Rev. Biochem. 62, 385–427 (1993).
Wright, S. H. & Wunz, T. M. Am. J. Physiol. 253, F1040–F1050 (1987).
Montrose-Rafizadeh, C., Mingard, F., Murer, H. & Roch-Ramel, F. Am. J. Physiol. 257, F243–F251 (1989).
Takano, M., Inui, K.-I., Okano, T., Saito, H. & Hori, R. Biochim. biophys. Acta 773, 113–124 (1984).
Sokol, P. P. & McKinney, T. D. Am. J. Physiol. 258, F1599–F1607 (1990).
Thiebaut, F. et al. J. Histochem. Cytochem. 37, 159–164 (1989).
Ullrich, K. J., Papavassiliou, F., David, C., Rumrich, G. & Fritzsch, G. Pfluegers Arch. 419, 84–92 (1991).
David, D., Rumrich, G. & Ullrich, K. J. Krongreβ der Gesellschaft für Nephrologie Hamburg. Abstr. 472 (Dustri, München, 1994).
Pacholczyk, T., Blakely, R. D. & Amara, S. G. Nature 350, 350–354 (1991).
Schömig, E., Babin-Ebell, J. & Russ, H. Naunyn-Schmiedeberg's Arch. Pharmac. 347, 379–383 (1993).
Magagnin, S. et al. J. biol. Chem. 267, 15384–15390 (1992).
Kozak, M. Nucleic Acids Res. 12, 857–872 (1984).
Hohage, H., Mörth, D. M., Querl. I. U. & Greven, J. Pharmac. Exp. Ther. 268, 897–901 (1994).
Gingrich, J. A. et al. FEBS Lett. 312, 115–122 (1992).
Schömig, E. & Schönfeld, C.-L. Naunyn-Schmiedeberg's Arch. Pharmac. 341, 404–410 (1990).
Trendelenburg, U. in Handbook of Experimental Pharmacology (eds Trendelenburg, U. & Weiner, N.) 279–319 (Springer, Berlin, 1988).
Russ, H., Gliese, M., Sonna, J. & Schömig, E. Naunyn-Schmiedeberg's Arch. Pharmac. 346, 158–165 (1992).
Veyhl, M. et al. J. biol. Chem. 268, 25041–25053 (1993).
Kyte, J. & Doolittle, R. F. J. molec. Biol. 157, 105–132 (1982).
Sanger, F., Nicklen, S. & Coulson, A. R. Proc. natn. Acad. Sci. U.S.A. 74, 5463–5467 (1977).
Chomczynski, P. & Sacchi, N. Analyt. Biochem. 162, 156–159 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gründemann, D., Gorboulev, V., Gambaryan, S. et al. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372, 549–552 (1994). https://doi.org/10.1038/372549a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/372549a0
This article is cited by
-
Quassinoid analogs with enhanced efficacy for treatment of hematologic malignancies target the PI3Kγ isoform
Communications Biology (2020)
-
Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma
BMC Cancer (2018)
-
Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol
Systematic Reviews (2018)
-
Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase
Nature Medicine (2018)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.